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Abstract
Zonulin as a Mediator of Psychological Stress and Periodontal Disease
Casey D. Wright, MS
The prevalence of chronic inflammatory diseases is on the rise. Some have posited the
permeability of tight junctions in gastrointestinal epithelium tissues as a potential mechanism for
precipitating inflammatory processes throughout the body. Zonulin is the only known modulator
of tight junction permeability and has been implicated in numerous chronic inflammatory
processes (e.g., proinflammatory cytokine production) and diseases, more generally. The role of
zonulin in oral inflammation, however, has yet to be explored. Periodontal disease is the most
common oral inflammatory condition and primary perpetrator of tooth loss. Periodontal disease
also is associated with a number of other health problems including heart disease and stroke and
has previously been associated with psychological stress. The exact mechanisms between stress
and inflammation, including in the periodontium, however, are less known. Thus, this
dissertation was aimed at exploring whether moderate-to-severe periodontal disease was
associated with higher levels of zonulin when compared to mild periodontal disease or otherwise
healthy gingiva. Second, this study evaluated the mediating role of zonulin in helping to explain
the relation between psychological stress and cytokines in participants with periodontal disease.
Participants included 114 individuals (50.9% women, Mage = 36.1 years, SD = 14.0) from greater
Morgantown, West Virginia who were part of a larger research project examining biobehavioral
contributors to oral inflammation. Participants provided demographic and basic health
information, a serum sample, underwent a periodontal examination, and filled out a battery of
psychosocial questionnaires. Results indicated a potential relation between zonulin and
periodontal disease status. In particular, zonulin was a significant predictor of number of teeth
with probing depths of 5 millimeters or more in non-smoking individuals (β = 0.25, p = 0.029).
Zonulin also was associated with indicators of more acute stages of periodontal inflammation,
including the number of teeth with a probing depth of 5mm or more in a stepwise regression that
included many common risk factors of periodontal disease. Additionally, dietary factors such as
B-vitamins were associated with serum zonulin levels. Psychosocial variables, however, were
not associated with zonulin or periodontal variables as anticipated. Other exploratory analyses
were indicative of potential relations with depressive symptoms and zonulin, along with
periodontal parameters. The results of this study provide preliminary implications for the role of
zonulin and gastrointestinal distress in oral inflammation.
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Zonulin as a Mediator of Psychological Stress and Periodontal Disease
Introduction

Over the last two decades, there have been substantial advances in discovering and
understanding the distinguishing characteristics of the protein zonulin and its role in
inflammatory processes. Zonulin is a regulator of intestinal epithelial tissue permeability, which
is a primary barrier to the outside world. Much of this prior work has focused on the
functionality of increased zonulin being associated with a leaky gut in the pathogenesis of
numerous chronic inflammatory diseases (Sturgeon & Fasano, 2016). No known study, however,
has investigated the role of zonulin in oral inflammatory diseases, such as periodontal disease.
Additionally, growing evidence has been suggestive of a relation between psychological stress
and increased risk for periodontal disease (Genco & Borgnakke, 2013; Warren et al., 2014), yet
the mechanism(s) involved in this association also are unclear. This dissertation examined the
role of zonulin in the observed association between stress and periodontal inflammatory
parameters.
Rise of Inflammation
The hygiene hypothesis has been one theory offered as an explanation for the steady
increase in diseases rooted in inflammation since the 1950s (Bach, 2002). The hygiene
hypothesis suggests that contemporary chronic inflammatory diseases may result from oversanitation, which reduces early-life exposure to pathogens that typically program the developing
immune system, resulting in a phenotype that is susceptible to autoimmunity, chronic
inflammation, and allergic reactions (Bach, 2002). A second landmark article proposed the
microflora hypothesis, claiming that the Western diet and medicinal practices (e.g., high
antibiotic use) in industrialized countries have disrupted the microbiome, leading to increased
risk for inflammatory disease (Noverr & Huffnagle, 2005). Although researchers continue to
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consider many possible contributing factors, evidence supports the import of inflammatory
processes in diseases, including emotional maladies (Bach, 2002; Noverr & Huffnagle, 2005;
Segerstrom & Miller, 2004). Particularly with the decrease in infectious disease, exploring
mechanisms of microbiome dysbiosis—in the gut, the oral cavity, and other bodily systems—
remains vital to the understanding of diseases of the future (Fasano & Flaherty, 2021).
Importance of Gut in Development and Maintenance of a Functional Immune System
The digestive system, and more specifically the gastrointestinal (GI) tract, is one area
generally affected by inflammatory processes. As a system tasked with numerous immunerelated functions, the gastrointestinal tract encapsulates both the gates and gatekeepers to the rest
of vital organ systems (Sturgeon & Fasano, 2016). Indeed, the digestive system is foundational
to keeping an organism “safe” from toxins, while also allowing for necessary nutrients to pass
into the bloodstream and body. This ability to allow the “good” to enter and keep the “bad” out is
a complex physiological process of epithelial function and thereby, tissue permeability, and is
well studied in microbiology (Arrieta, Bistritz & Meddings, 2006; Bischoff et al., 2014, Fasano
& Shea-Donohue, 2005). Tissue permeability (i.e., the phenomenon that certain types of tissue
are pervious and able to be passed through by certain substances) is facilitated by a number of
microbiological processes not within the scope of this dissertation (see Bischoff et al., 2014).
Suffice it to say, however, that these processes include understanding “tight junction”
complexes, or the specific channels in the tissue, and their role in epithelial tissue being more or
less permeable to either nutrients or toxins entering an organism (Sturgeon & Fasano, 2016).
Increased tissue permeability, particularly in the gastrointestinal tract, has oft been described as
leaky gut (Sturgeon & Fasano, 2016), depicting the idea that given the proper circumstances,
tissues may allow toxins into the system, necessitating a defensive immune response.
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Zonulin and inflammation. Discovered in the early 2000s, zonulin is the only known
regulator of tight junction complexes embedded in epithelial tissues and is partly responsible for
increased permeability of said tissues (Fasano, 2011; Fasano & Nataro, 2004; Sturgeon &
Fasano, 2016). Though most well studied in the gut, zonulin may also affect the permeability of
the blood-brain barrier (Sturgeon & Fasano, 2016) and vascular tissues (Ciccia et al., 2017).
Within the gut, elevated levels of zonulin increase the permeability of the intestinal epithelial
barrier, allowing larger molecules to leave the gut lumen and infiltrate the body. Zonulin
upregulation results in the disruption of the gut microbiome (i.e., dysbiosis) and ultimately an
increased activation of innate (e.g., short-term, initial) and adaptive (e.g., long-term, more
targeted) immune processes, including the systemic release of immune mediators (Sturgeon &
Fasano, 2016). These mediators, including pro-inflammatory cytokines, antibodies, or in some
cases, autoantibodies, travel in the peripheral circulation and can impact distal organs (e.g., the
brain).
Zonulin is a 47 kilodalton size protein regarded as a member of the complementassociated proteins family and is produced intracellularly within epithelial cells (Fasano, 2011).
It has been found to be synonymous to pre-haptoglobin 2, which is the precursor to haptoglobin
molecules (produced via genes HP1 and HP2 from chromosome 16) and primarily affects the
upper gastrointestinal tract, meaning the jejunum and the distal ileum (Sturgeon & Fasano,
2016). Additional and comprehensive microbiological characterizations of zonulin are described
elsewhere (Fasano, 2011; Surgeon & Fasano, 2016). Notably, the health significance of zonulin
and intestinal permeability is, to date, best characterized in the autoimmune disorder, celiac
disease. Here, gliadin (a protein found in wheat, barley, and rye) binds with CXCR3 receptors at
a tight junction complex, which triggers zonulin release and results in increased intestinal
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permeability (Sturgeon & Fasano, 2016). In genetically predisposed individuals (with gene
variants HLADQ2/DQ8), this process triggers the development of autoantibodies that attack the
small villi of the upper small intestine leading to diarrhea, malabsorption, and oral symptoms
(among other extra-intestinal symptoms) such as chronic recurrent aphthous ulcers/canker sores
and tooth enamel deficiencies (Malahias et al., 2010). Although not as well-characterized,
zonulin also is believed to play a pathogenic role in a number of other chronic inflammatory
conditions, including diabetes and other metabolic diseases, and autoimmune diseases such as
multiple sclerosis, colitis, polycystic ovary syndrome, asthma, coronary artery disease, and HIV,
among others (Sturgeon & Fasano, 2016; Zhang et al., 2014). Figure 1 displays a theoretical
pathway, or directed acyclic graph (DAG), of zonulin and how it may contribute to
inflammation.
Accumulating data have demonstrated the key roles that the gut and gut distress play in
health and disease by communicating with the immune system and involvement in a variety of
metabolic processes (Burcelin, 2016). By modulating intestinal barrier permeability, zonulin
likely plays a pathogenic role in a range of inflammatory diseases (Sturgeon & Fasano, 2016).
Periodontal disease also is a chronic inflammatory condition and co-occurs with other diseases
linked to zonulin. For example, associations have been demonstrated between diabetes, oral
microbiome disruption, and periodontal disease (Xiao et al, 2017). Though there is theoretical
justification, to date, the possible role of zonulin and gut-related distress or dysbiosis in the
pathogenesis of oral inflammation remains unknown. Zonulin-related diseases (e.g., celiac
disease), however, do involve oral symptomology (e.g., canker sores, enamel deficiencies;
Malahias et al., 2010). Patients with other oral inflammatory diseases (e.g., Sjogren’s syndrome)
also experience comorbidities with zonulin-related diseases (e.g., celiac disease; Kim-Lee et al.,
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2015). Research assessing the association between celiac disease and periodontal disease
specifically is only in its infancy, with only one known study examining the relations. Results
were inconclusive due to methodological limitations (Spinell et al., 2017). Moreoever, zonulin
levels affect vascular tissues which are densely distributed within the oral cavity (Ciccia et al.,
2017). Thus, it is important to explore the potential role of zonulin in oral diseases either through
gut permeability or potentially through oral tissue permeability.
Mouth as the Beginning of the Digestive System
While seen as a predominately gastrointestinal phenomenon, the digestive system truly
begins with the oral cavity. In light of the existence of junctional epithelial tissues in the
periodontium, it could be that zonulin directly affects the epithelial tight junction structures in
the mouth, leading to “oral tissue permeability” and resultant inflammatory processes.
Periodontal diseases have previously been characterized as biologically caused and host
mediated (Tonetti, Greenwell, & Kornman, 2018), though the mechanism(s) by which bacteria is
allowed to infiltrate junctional epithelial tissues within the gums are unknown. The idea of oral
tissue permeability could implicate zonulin as a gatekeeper (in certain genetically predisposed
individuals) that allow bacteria such as p. gingivalis to trigger an immune response with
collateral damage such as breakdown of tooth structure and bone loss. Additional work is
needed, though, to explore this area.
Alternatively, given that the gastrointestinal tract is the primary interface with the outside
world for humans (Fasano & Flaherty, 2021) and, as stated previously, zonulin binds more
heavily in the upper intestinal tract, most work has assumed an inflammatory response starting in
the gut and traveling elsewhere throughout the body (Fasano, 2011; Sturgeon & Fasano, 2016).
This could be the case for the role of zonulin in periodontal disease as well, meaning periodontal
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inflammation could be a result of dysfunctional gut-immune activity. That is, perhaps increased
tissue permeability in the gut leads to an inflammatory response in certain predisposed
individuals who go on to develop periodontal inflammation or have inflammation manifest
within the oral cavity.
Preliminary work with self-reported gut distress and periodontal disease has indicated a
potential relation between the two, such that gut distress was positively associated with selfreported periodontal inflammation (Wright et al., 2021a). Similarly, other evidence has
demonstrated a robust connection between the “gum-gut axis” (Byrd & Gulati, 2021). Whether
zonulin affects local tissues or the broader system, no known data exists to understand the
relation between zonulin and periodontal inflammation. Given that the most reliable method for
quantifying zonulin is via serum accessed via the blood (as opposed to a saliva swab), this study
started with and focused on the systemic route of action beginning in the gastrointestinal tract.
Periodontal Disease
Nearly half (45.9%) of the United States adult population of those 30 years and older, or
about 64 million Americans, suffer from periodontal disease (Eke et al., 2015). Periodontal
disease is a chronic inflammatory disease typically measured via probing into the pocket
between the tooth and adjacent gingival tissue (i.e., sulcus) of multiple sites per tooth, combined
with any recession present to equate a measure of attachment loss, in addition to radiographic
imaging (Tonetti et al., 2018). These various clinical parameters, such as probing depth and
attachment loss, in addition to bleeding on probing, plaque scores, tooth mobility, among others,
each provide a nuanced perspective to an otherwise etiologically and ontologically complex
array of conditions (i.e., periodontal diseases). That is, probing depth and bleeding on probing
typically are indicators of acute inflammation (Eke, Borgnakke, & Albandar, 2021). Parameters
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such as attachment loss, however, provide a measure of how much the gingival tissues and
supporting structure (i.e., alveolar bone) have resorbed and are signs of progression and later
stages of periodontal disease (Eke et al., 2021; Tonetti et al., 2018). Moreover, bone loss, or the
degradation of the alveolar bone, also is possible, further destabilizing the tooth structure,
ultimately leading to tooth loss, and is seen via radiograph, which can be the final outcome or
endstage of periodontitis (Eke et al., 2021; Tonetti et al., 2018).
Classification, diagnosis, and treatment of periodontal conditions. The official
classification of periodontal diseases has been altered from time to time (see Highfield, 2009;
Tonetti et al., 2018), with the latest classification shifting to a staging and grading system
(Tonetti et al., 2018). One of the most commonly used classifications has been a combined effort
between the Centers for Disease Control and the American Academy of Periodontology
(CDC/AAP). The CDC/AAP classification was based on a combination of probing depth and
attachment loss parameters. Other periodontal disease classification or measurement efforts have
been tested, including an attempt to identify phenotypic profiles based on clinical parameters
(Periodontal Profile and Tooth Profile Classes; Morelli et al., 2017) or through patient-report
questionnaires (Blicher, Joshipura, & Eke, 2005; Chatzopoulos, Tsalikis, Konstantinidis, &
Kotsakis, 2016; Wright, Heaton, & McNeil, 2021b), which have advantages related to being
cost-effective, efficient to administer, and scalable to population groups (DeVellis, 2017).
In general, periodontal disease exists on a continuum, ranging from a mild form—
gingivitis—to a more destructive form—aggressive periodontitis (National Institutes of Health,
2019). Gingivitis is inflammation of the gingiva, or gums, which normally are prevented via
basic dental hygiene practices such as brushing, flossing, regular dental cleaning appointments
(National Institutes of Health, 2019). Periodontitis is “inflammation around the tooth” (National
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Institutes of Health, 2019, p. 3), and can progress to the surrounding tissues such as ligaments or
connective bone, and is related to serious long-term implications.
Treatment for periodontal disease varies depending on severity of inflammation and
attachment. Both non-surgical (e.g., scaling and root planing, medications) and surgical (e.g.,
flap procedures, grafts) treatments have demonstrated efficacy in ameliorating periodontal
disease and reducing inflammation (National Institute of Dental and Craniofacial Research,
2017). Scaling and root planing involve scraping away any plaque, tartar, and calculus that has
built up in the pockets and around the periodontal tissues, as well as smoothing any rough spots
that may collect bacteria, thus alleviating the inflammation caused by the bacteria and resultant
collateral damage (National Institute of Dental and Craniofacial Research, 2017). Flap
procedures or grafts include alterations to gingival tissue such as cutting away tissue or
displacing it for better access as a way to remove calculus or to actually replace lost soft tissue
(National Institute of Dental and Craniofacial Research, 2017). Reversing bone loss as a result of
periodontal disease, or growing new bone, still remains a challenge in treatment. For those who
lose teeth due to periodontal disease, if the supporting structures allow, implant technologies are
available.
Risk factors of periodontal disease. Inflammation from periodontitis has suspected
systemic effects and has been linked to increased risk for a number of aging-related diseases
(e.g., stroke, myocardial infarction; Eke et al., 2016; Gargano & Hughes, 2014) and to aging
itself (Ebersole et al., 2016). Both biological (e.g., genetic) and behavioral/psychological factors
(e.g., diet, stress, depression) have been associated with periodontal disease (Genco &
Borgnakke, 2013; Kinane et al., 2017; Warren et al, 2014; Wright et al., 2017). Fewer studies,
however, have examined the role of psychological variables in the pathogenesis of periodontal
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disease. Nevertheless, stress has been associated with altering gut processes related to intestinal
permeability (Lyte et al., 2010; Moloney et al., 2015) which, as mentioned previously, has been
implicated in other inflammatory diseases. Tissue permeability may be one way to explicate the
relation between stress and the pathogenesis of periodontal inflammation.
Psychological Stress and Periodontal Disease
Common risk factors such as the presence of p. gingivalis and smoking status predict
some but not all of the variance in periodontal diseases. That is, periodontal disease is
biologically caused, and host mediated (Tonetti et al., 2018). Given this mediation by host
factors, psychological variables have been implicated as potential risk factors, though less is
known as to how they may be associated. More broadly, the association of psychological stress
with increased susceptibility to inflammatory processes is well known, including the complex
relation between stress, cytokine expression, and different components of the immune system,
including temporal variegations of stress such as acute versus chronic forms (Segerstrom &
Miller, 2004; Slavich & Irwin, 2014).
In the case of periodontal disease, psychological stress is related to the development of
pathological processes (Aleksejuniené et al., 2002; Dumitrescu, 2006; Genco et al., 1999;
Hildebrand et al., 2000; Ng & Keung Leung, 2006; Warren et al., 2014). Although most of these
studies report that psychosocial factors (including life stress) are positively associated with
periodontal disease, more work needs to be done in this area (Genco & Borgnakke, 2013). It
remains unclear whether psychological stress directly affects biological mechanisms involved in
disease development or whether people who are stressed make life choices that affect their
biology (e.g., smoking, poor diet) and lead to periodontal disease (Dumitrescu, 2006). In addition
to the evidence suggesting the role of gut distress and periodontal inflammation mentioned

ZONULIN, STRESS, AND PERIODONTAL DISEASE

10

earlier, this work also has demonstrated the role of gut distress as a mediator in the relation
between psychological stress and self-reported periodontal inflammation (Wright et al., 2021a).
Thus, one way to better understand the role of psychological stress in periodontal disease is to
know whether zonulin, a biomarker of gut distress, mediates basic stress and inflammatory
indicators.
As already mentioned, prior work has shown how zonulin also plays a role in the
pathogenesis of inflammation (Sturgeon & Fasano, 2016). Once zonulin breaks down the tight
junction complex in epithelial tissues and the barrier function of the mucosa is compromised,
toxins and antigens can more readily access the body. The role of zonulin in relation to
psychological stress and ensuing pro-inflammatory cytokines is, however, largely unknown.
Though some work has shown a relation between stress and intestinal permeability (Lyte et al.,
2010), only one known preliminary rodent study has examined the role of stress and its effects
on zonulin, in which it was found that exercised (i.e., “stress-induced”) rats had higher levels of
zonulin than sedentary rats (Holland et al., 2015).
Acute and chronic stress in relation to the immune system. Psychological stress is
contextualized primarily in terms of temporality, meaning whether it is experienced acutely or
chronically (Felicione, Blank, Wright, & McNeil, 2021). Differences in immune function are
associated with various types of stress and the literature describing these functions—
psychoneuroimmunology—is complex (Segerstrom & Miller, 2004). Broadly stated, immune
responses in human organisms are described in terms of the innate immune response and the
adaptive immune response. The innate immune response is a broader, less targeted reaction to
potential threats within the body (Segerstrom & Miller, 2004). Immune cells react in such a way
that is more immediate, but due to the less targeted approach, can be less effective at eliminating
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the threat, though act as “first responders” at the scene until the more targeted and powerful
immune response can be activated (Segerstrom & Miller, 2004). This more targeted system is the
adaptive immune reaction, in which cells tailor their attack based on the intruder (Segerstrom &
Miller, 2004).
Concerning the latter response, namely adaptive (i.e., the more long-term and targeted)
immune processes, consistent evidence shows that chronic psychological stress relates to a
down-regulation of immune function, leaving the body vulnerable to infection. A different
pattern is observed, however, when innate (i.e., initial and more broad) immune processes are
examined. Here, chronic stress is associated with increased susceptibility to prolonged
inflammation that may play a role in the etiology of diseases (Slavich & Irwin, 2014), such as
periodontal disease.
Acute and more chronic types of stress are associated with increased circulating levels of
pro-inflammatory mediators, such as the cytokine, interleukin (IL)-6 (Segerstrom & Miller,
2004). Since IL-6 is a pro-inflammatory cytokine, it is typically associated with greater levels of
systemic inflammation, which is associated with comorbidities of periodontal disease such as
heart disease, diabetes, and osteoporosis (Segerstrom & Miller, 2004). IL-6 also is one of three
proinflammatory cytokines with a substantial role in the breakdown of tissues that are a main
symptom of periodontal disease (Nikolopoulos et al., 2008; Tawfig, 2016). Others have noted the
importance of IL-6 in both acute and chronic inflammation, making it important to understand in
the etiology and development of periodontal disease (Tawfig, 2016).
Statement of the Problem
The oral cavity is the beginning of the digestive system or process (e.g., to extract
nutrients and protect the organism) and include complex interactions among the oral
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microbiome, the act of chewing, salivary functions, and immune responses, among others. The
human digestive tract is similar in function to skin, in that its purpose is to protect the host from
harmful organisms, while still absorbing important nutrients (Fasano & Nataro, 2004; National
Institute of Diabetes and Digestive and Kidney Diseases, 2013). Little work has been done,
however, to examine the role of gastrointestinal functions and factors in influencing or being
associated with the oral cavity and its processes. Specifically, no known study has examined
zonulin, a regulator of gut permeability, in oral diseases or in the relation of behavioral factors,
such as stress, to oral inflammatory processes.
Conducting this study aids in the declared vision of the National Institute of Dental and
Craniofacial Research (NIDCR), namely helping to understand “a world where dental, oral and
craniofacial health and disease are understood in the context of the whole body” (Somerman,
2017). It further builds interdisciplinary efforts to understanding oral disease, including how
behavior interacts with basic underlying biological processes (National Institute of Dental and
Craniofacial Research, 2014-2019).
Given the exploratory nature of this study, the a priori theoretical model hypothesizing
the role of zonulin in periodontal disease was twofold. First, prior literature implicating zonulin
in extraintestinal diseases suggest it starts in the gut and then inflammatory processes go
elsewhere, as is depicted in Figure 1, with “chronic inflammation” alluding to inflammation
anywhere in the body (Sturgeon & Fasano, 2016). This is one theoretical starting point for
periodontal disease such that zonulin affects the gut and thereby settles in the oral cavity and is
mediated by other risk factors such as stress, diabetes, body mass index (BMI), and other
covariates. It also could be, however, that zonulin directly effects the oral cavity via junctional
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epithelial tissues and is moderated via interacting covariates such as BMI, diabetes, or oral
hygiene factors.
The purpose here was to explore the role of zonulin in periodontal disease more
generally, and well as the role of zonulin as a mediator of psychological stress and inflammation
in periodontal disease patients. In the preliminary study mentioned previously, self-reported
visceral sensitivity (gut anxiety/distress) mediated the relation between self-reported
psychological stress and a self-report measure of periodontal disease while accounting for age,
sex, education, and income (Wright et al., 2021a). Given the results of this preliminary study and
the literature examining zonulin, gut-related permeability, and inflammation (Fasano, 2011), two
a priori hypotheses were evaluated in this dissertation, and several exploratory post hoc
hypotheses also were considered.
First, given the association between zonulin and numerous chronic inflammatory
diseases, it was hypothesized that patients with moderate to severe periodontal disease would
have higher levels of zonulin. That is, patients with moderate-to-severe periodontal disease
would have zonulin levels that were significantly higher than those with little to no disease.
Second, because other mechanism(s) potentially explain the association between
psychological stress and cytokine levels are less understood, it was hypothesized that zonulin
levels would mediate the relation between stress and IL-6 levels. That is, it was hypothesized
that greater psychological stress would be associated with greater zonulin levels, which would in
turn be associated with greater IL-6 levels. Likewise, it was anticipated that an indirect effect
would exist such that the relation between stress and IL-6 levels would be partially explained by
zonulin levels, all while controlling for covariates such as gender, age, smoking status, diabetes,
and BMI.
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Method
Participants and Procedure
As part of a larger cross-sectional project comprised of a number of biological and
psychosocial variables, this dissertation included a cross-sectional sample of 114 adult
community participants between the ages of 18 and 77 years old with varying levels of
periodontal disease, or the absence of disease, recruited from greater Morgantown, West
Virginia. The larger project was originally targeted to explore biobehavioral correlates of oral
inflammation and included the collection of various biological (e.g., whole blood, serum, saliva,
gingival crevicular fluid) and psychosocial (e.g., anxiety, depression, disgust, diet) data, not all
of which are included in the aims of the dissertation. Participants were recruited through a
convenience sampling method including distributing advertisements in dental clinics or nonprofit organizations, word of mouth, and from periodontal patients in the faculty practice at the
West Virginia University School of Dentistry. Eligible participants with periodontal disease or
no disease were included, unless they were currently undergoing periodontal treatment. Those
with past treatment were still included in the study. Utilizing the 2012 CDC/AAP case
definitions (see Table 1), a target distribution was anticipated to be and was similar to that of
other studies in other population groups (i.e., 15-20% severe, 30-40% moderate, 10% mild, and
15-20% little to no disease). Data collection and management was facilitated using REDCap
(Harris et al., 2009). All procedures were conducted in accordance with West Virginia
University’s Institutional Review Board (Protocol #1902473418) requirements and procedures.
To narrow the scope and focus of the study on inflammation-related etiology of
periodontal disease, individuals experiencing other oral inflammatory conditions (e.g., herpes,
aphthous ulcers or canker sores, Steven-Johnson condition, oral lichen planus), pregnant women,
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and individuals on anti-inflammatory medications, and participants with fewer than eight of their
natural were excluded from participation. Likewise, as with NHANES (National Health and
Nutrition Examination Survey, 2013) periodontal examinations, individuals with a history of a
heart transplant, artificial heart valve, heart disease necessitating prophylactic antibiotics, or
bacterial infection of the heart were excluded. Other disease information was collected as part of
the demographic data to gather information about other chronic inflammatory diseases such as
lupus or celiac disease. After expressing interest in the study, potential participants were
screened via telephone or email to ensure eligibility. Upon arrival to the study site (i.e., West
Virginia University Suncrest Towne Center Dental Clinic), participants completed the informed
consent process, and provided demographic data including self-reported health information.
The first participant was enrolled on September 18, 2019. After the onset of the COVID19 pandemic, after enrolling 51 participants, recruitment was paused from March 14, 2020 until
September 16, 2020, when data collection resumed. Additional safety protocols were initiated
including research staff wearing additional personal protective equipment, calling participants
the night before their appointments to screen for COVID-19 symptoms, as well as re-asking the
COVID-19 questions and taking a temperature before allowing the participant to enter the
facility. Participants had to endorse they were not experiencing COVID-19 symptoms and to
have a temperature of less than 100.4 degrees Fahrenheit in order to participate. After enrolling
34 participants and after another spike in new cases in the Morgantown, WV area, recruitment
was again paused from December 5, 2020 until February 27, 2021, when the study was resumed,
and another 29 participants were recruited. The last day of data collection was March 19, 2021.
Biospecimen collection. After consenting and the demographic and health history data
were collected, a trained phlebotomist conducted a screening for the blood draw that included
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questions about current medications, and illnesses/vaccinations/tattoos in the last two weeks.
Next, the phlebotomist conducted a standard venipuncture blood draw of 8 milliliter (mL),
including one 5mL vacutainer for serum (yellow cap with separating gel) and one 3mL
vacutainer (lilac cap) for whole blood to be used for derivation of biological variables. After
resting for approximately 15 minutes to allow for coagulation, the 5mL vacutainer was placed in
centrifuge for 10-15 minutes and the resultant serum was aliquoted into three 500 microliter
Eppendorf tubes. Eppendorf tubes were then immediately placed in a freezer (-80℃) and later
transported to another such freezer on the Health Sciences Campus of West Virginia University
for long-term storage. To determine the quantitative value (ng/mL) of zonulin present in the
serum, the second aliquot of serum for each participant was used and an ELISA
(Immundiagnostik) procedure was conducted. A reference range by Immundiagnostik (n = 40),
the company that produces the kit included a median value of 34 ng/ml (SD = 14 ng/ml).
Moreover, because of its relevance in systemic inflammation and its key role in the destruction
of periodontal tissues (Tawig, 2016), the quantitative value of interlukin-6 (IL-6) also was
determined using ELISA (R & D Systems). In the protocol, R&D systems stated in a normative
sample of 40 participants, 33 samples had IL-6 values of less than 3.13 pg/mL and 7 samples
were between 3.13 and 12.5 pg/mL. Standard procedures and protocol for both ELISA kits,
including running samples in duplicates, were followed by an outsourced laboratory (i.e., Dr.
Jennifer Franko at West Virginia University).
Periodontal examination and assessment. Following the blood draw, a periodontal
examination was conducted by one of two trained and calibrated dental examiners, including one
board-certified periodontist or a periodontics resident. Repeat examinations on about 10% of the
participants were conducted in order to determine intra- (i.e., compared to self) and inter- (e.g.,
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periodontist repeat of resident) examiner reliability. All study-related periodontal examinations
were conducted according to the NHANES (National Health and Nutrition Examination Survey,
2013) oral health examination procedures.
The examiner probed six sites per tooth (excluding third molars), using a periodontal
probe graduated from 2 to 12 mm. First, the distance between the free gingival margin (top of
gum) and the bottom of the sulcus (i.e., pocket depth) was measured. Next, a measure of the
distance between the free gingival margin and the cemento-enamel junction (CEJ) was taken. For
cases in which the gingival margin was below the CEJ (i.e., measure of gingival recession),
recession was documented. Each of these measures was taken from the mesial, mid, and distal
sites on both the buccal (cheek) and lingual (tongue) sides of each tooth (i.e., six sites per tooth).
Each measurement was called out by the examiner to a trained research assistant and recorded on
a printed paper chart. Bleeding on probing was recorded for each site probed, and plaque scores
were recorded for the mesial, mid, and distal sites of the buccal side and the mid site on the
lingual (i.e., total of four sites per tooth). Number of missing teeth also was recorded. If data
were collected from one of the two examiner’s patients recruited in the periodontics specialty
practice, their initial examination data were utilized by the dental provider giving the charted
numbers (deidentified from HIPPA-related information) to a research staff member.
Pen-and-paper-recorded values were then entered into an excel spreadsheet that used
various formulas to calculate and provide a number of other periodontal parameters. Clinical
attachment loss was calculated as the sum of the probing depth and recession in millimeters if the
gingival crest was below the CEJ. If above the CEJ, attachment loss was calculated by
subtracting the distance from the CEJ to the gingival crest from the probing depth. Additionally,
average probing depth, average attachment loss, number of missing teeth other than third molars,
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the percent of sites that bled on probing, the percentage of sites with plaque, and the number of
teeth with probing depths greater than or equal to 4 millimeters (mm) or 5 mm, as well as the
number of teeth with clinical attachment loss greater than or equal to 3mm, 4mm or 6mm were
calculated. Using these parameters, the excel sheet calculated the data and determine the
CDC/AAP status categorizations (e.g., no disease, mild, moderate, severe), and are described in
Table 1.
Psychosocial and diet assessments. Following the periodontal examination (or in some
cases, while waiting for the periodontal examination), a battery of psychosocial questionnaires
on REDCap was administered via a computer tablet. As a part of the greater battery of
questionnaires, the two primary measures initially completed included the Perceived Stress Scale
(PSS-10; Cohen & Williamson, 1988) and the Life Events List (LEL; Cohen, Tyrrell, & Smith,
1991). The PSS-10 is a well-established, reliable, and valid assessment designed to measure
everyday perception of stress. It includes 10 items and is a standard measure of overall stress
(Cohen, Kamarck, & Marmelstein, 1983; Cohen & Williamson, 1988). The PSS-10 has shown
strong psychometric properties including good internal consistency (α = 0.78-0.91; Lee, 2012),
and good evidence for convergent and discriminant validity (Lee, 2012). Normative data have
previously been published, including means ranging from 11.41-20.21 depending on the sample
and demographic information (e.g., 1983 vs. 2009; employed vs. unemployed; Cohen & JanickiDeverts, 2012).
The LEL (Cohen et al., 1991) was originally derived, in part, from the List of Recent
Experiences (Henderson et al., 1981). This instrument has evidence for validity (Cohen et al.,
1991; Cohen, Tyrrell, & Smith, 1993), though no known evidence has been provided for internal
consistency or other reliability measures. The LEL was used, though, because it can be
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administered in one sitting and takes a number of more common stressful events into account
than other competing measures such as the Life Events Checklist (Weathers et al., 2013), which
is more trauma focused. The LEL includes a number of items and can provide a metric of
stressors and takes into account whether it was a positive or negative valence (e.g., ending a
relationship, but an abusive one) and was employed to provide additional perspective about
varying types of stress (e.g., chronic, acute, time-limited, naturalistic, positive or negative
stressors).
The other psychosocial variables collected as part of the larger project were included in
post-hoc exploratory analyses and are described here. The Center for Epidemiologic Studies
Depression (CESD; Radloff, 1977) scale includes 20 items targeted at assessing depressive
symptomology. It has been well-validated and utilized broadly (Radloff, 1977).
The Fear of Pain Questionnaire-9 (FPQ-9; McNeil et al., 2018) is a nine-item short-form
of its parent measure, the Fear of Pain Questionnaire-III (FPQ-III; McNeil & Rainwater, 1998),
and has demonstrated evidence for reliability and validity (McNeil et al., 2018). The FPQ-9
measures the fear associated with painful experiences such as falling down concrete steps,
getting a paper cut, or injections as part of a medical or dental procedure. Fear of pain has been
implicated in pain perception (McNeil et al., 2011), poorer medical or dental procedure and
utilization outcomes (Chen et al., 2019; McNeil et al., 2018), and varies with age (Wright &
McNeil, 2021).
The Anxiety Sensitivity Index-3 (ASI-3; Taylor et al., 2007) includes 18 items that assess
the fear of anxiety sensations. Well-validated and used broadly, the ASI-3 assesses differences in
anxiety proneness, particularly as they relate to physiological, cognitive, and social anxiety
symptoms (Taylor et al., 2007).
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A similar measure targeted on gut-specific anxiety, the Visceral Sensitivity Index (VSI;
Labus et al., 2004) targets sensations and anxiety symptoms (e.g., looking for a restroom at new
restaurants, worry about bloating) often experienced by those with gastrointestinal distress
(Labus et al., 2004; Labus et al., 2007). It has demonstrated evidence for reliability and validity,
particularly when used with individuals that have irritable bowel syndrome or other
gastrointestinal complaints (Labus et al., 2004; Labus et al., 2007; Wright et al., 2020).
The Periodontal Disease Self-Report (PDSR; Wright et al., 2021b). includes items that
participants indicate both functional and physiological symptomology as it relates to periodontal
inflammation. Example items include “I can feel my teeth move when I chew” or “My gums
often bleed.” Psychometric analyses were used and provided good evidence of reliability and
factor validity in the initial validation of the measure (Wright et al., 2021b).
The Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24® 2018)
was used to collect diet data. The ASA24 is a self-administered 24-hour diet recall measure
created by a collaboration of various institutes at the National Institutes of Health. It is
administered via a web-portal and is free to use for researchers. Participants using the ASA24 are
asked to search a database and enter the foods, drinks, and supplements they consumed over the
prior 24 hours from the time of filling out the measure. The system then asks details about the
meals including where the food was acquired, with whom was it consumed, and other details.
The data from the tool is vast and includes information about quantities of vitamins, minerals,
various food groups, energy, and more. Prior versions of the measure have been evaluated and
validated (ASA24, 2021; Kipnis et al., 2003; Moshfegh et al., 2008); it is widely used in diet and
nutrition studies. Additional information about the ASA24 is available at
https://epi.grants.cancer.gov/asa24/.
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Data Management and Statistical Analyses
Psychosocial data from REDCap, diet data from the NIH-supported web-portal,
periodontal parameters from excel sheets, and biospecimen data all were merged into one master
dataset. The quality of data was screened for linearity, independence, normality, equality of
variance, and to determine the degree of multicollinearity (Keith, 2014). No models included
non-linear relations, data were independent (from only one time point). Data were normal based
on what would be expected or consistent with norms. That is, variables that were skewed lower
such as IL-6 or current smoking status were expected to be based on norms. Age was somewhat
skewed younger. The CDC/AAP status was skewed in the less pathological direction. Residual
plots were within normal limits with all of the variables from the first hypothesis. Equality of
variance was tested as part of the ANOVA conducted and age, smoking status, and BMI were
significant (p < 0.05) for Levene’s test, but when a Welch test was conducted (to account for
non-equal variance), results were essentially the same. In terms of multicollinearity, VIF scores
were checked for regression models and there was no evidence for issues related to
multicollinearity.
Missing data analyses were then conducted to test whether the data were missing
completely at random (MCAR) or missing at random (MAR) and multiple imputations were
used to account for missingness. Little’s MCAR test was run on the variables included in the
main hypotheses. Results indicated that the data are missing completely at random (MCAR; p =
0.755). Overall, six participants were missing zonulin and IL-6 data due to an inability to draw
blood, while two participants had fewer than eight teeth and did not undergo the periodontal
examination. BMI was calculated using height and weight, and due to missingness in the height
variable, seven participants did not have a BMI calculated. Overall, 93 participants had complete
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data across all variables. Given the data were MCAR, no imputations were conducted, and
analyses were conducted using pairwise deletion and listwise deletion in the PROCESS
mediation analyses. Missingness in all primary variables is depicted in Table 2.
First, to test the hypothesis of whether periodontal inflammation is associated with
zonulin levels, CDC/AAP periodontitis categories were collapsed across cases of moderate and
severe periodontal disease and assessed as a binary variable (0/1) as an attempt to present a
parsimonious result. This new variable was included in a multiple linear regression model with
individual zonulin levels as the outcome variable and accounting for the covariates of gender,
age, smoking status, BMI and participant diabetes status. While other covariates could have been
included in the models, the covariates were selected because of their relative importance in prior
literature studying risk factors in periodontal disease. Moreover, additional covariates would
have required more power which was balanced with feasibility of completing the overall project.
Analyses were conducted using SPSS 27 (IBM, 2020).
An a priori power analysis was conducted using G*Power 3.1 (Faul et al., 2009) to
determine the appropriate number of participants to detect a meaningful result for differences in
zonulin levels between those with moderate-to-severe periodontal disease and those who do not
meet the threshold of moderate disease using a regression model for analysis. To detect a small
effect size of 0.15 with a power set at 0.80, and a regression including 6 predictors (binary
periodontal status variable, and covariates of age, sex, diabetes, BMI, and smoking status) would
require 98 participants. Figure 2 depicts the analysis for hypothesis one.
To test the second hypothesis, a multiple linear regression mediation model was
conducted to assess the relations among psychological stress, serum zonulin, and serum cytokine
levels across all CDC/AAP disease categories using PROCESS in SPSS 27 (Hayes, 2013; IBM,
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2020). The predicting variable in the model was participant stress levels and the outcome
variable was IL-6 cytokine levels. Quantified zonulin (ng/mL) levels were included as the
mediator and age, gender, smoking status, BMI, and diabetes as covariates.
As with the first hypothesis, an a priori power analysis was conducted using G*Power
3.1 (Faul et al., 2009) to determine the sample size needed for the mediation analysis. In order to
detect an effect size of 0.15 with power set at 0.80, and a regression including 8 predictors
(perceived stress, zonulin levels, and covariates of age, gender, diabetes, BMI, and smoking
status), an effective sample size would require 109 participants. Figure 3 depicts the mediation
model for hypothesis two.
Results
Demographic Data and Sample Characteristics
The average age of participants was 36.1 years old (SD = 14.0, Range = 18-77). The
sample consisted of 58 (50.9%) women and 50 (43.9%) men, 3 (2.6%) identifying their gender
as “other” and 3 (2.6%) were missing or did not respond. In terms of race/ethnicity, the sample
consisted of 86 (75.3%) White individuals, 24 (21.1%) Black or African American, and one
(0.9%) Asian, one (0.9%) American Indian/Native American, one individual (0.9%) with a race
identity of “other,” and on (0.9%) was missing or did not respond. Participants’ average years of
education was 15.2 (SD = 2.9, Range = 8-21). The mean body mass index (BMI) was 28.2 (SD =
8.2, Range = 15.8-68.7). Regarding relevant medical conditions, four participants (3.5%) had
diabetes, including two with type I and two with type II diabetes. In terms of smoking status, 25
(21.9%) participants reported currently smoking some days or every day. Demographic
information are summarized in Table 2, including gender, age, race/ethnicity, household income,
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education, body mass index, number of cigarettes smoked per day, and whether the participant
had a diabetes diagnosis.
The board-certified periodontist completed 97 (85.1%) of the examinations, the
periodontics resident completed 15 (13.2%), and two individuals were not examined due to
missing teeth (1.8%). The periodontist completed 11 (11.3%) repeat examinations and was
reliable in terms of intra-examiner agreement between the initial probing depth and the repeat
probing depth; exact agreement was 79.0% and agreement within plus or minus 1 millimeter was
99.9%. Intraclass correlation coefficient (ICC) also was calculated using a two-way mixed model
and absolute agreement type in SPSS. A two-way mixed model was selected given its
amenability to greater statistical power and likelihood of approximating the results of a random
effects model. The average measures ICC for probing depth was 0.92. For the measures of the
free gingival margin, exact agreement was 84.4%, and agreement within plus or minus 1
millimeter was 99.9%. The average measures ICC was 0.96. No repeat examinations were
completed for the periodontics resident, but interrater reliability scores were conducted by
repeating one examination where the periodontist and the resident were compared with each
other and demonstrated evidence of reliability. The exact agreement for both probing depths and
free gingival margin measurements between the periodontist and the resident was 64.3%, and the
agreement within 1 millimeter was 98.2%. The ICC average measures coefficient was 0.63.
Kappa scores also were calculated to determine reliability of CDC/AAP categorizations. The
periodontist intra-examiner assessments were identical in terms of CDC/AAP status and thus
resulted in reliable results (κ = 1.00). Similarly, when examining the periodontist compared to
the resident, the categorization for that one participant was identical and thus reliable (κ = 1.00).

ZONULIN, STRESS, AND PERIODONTAL DISEASE

25

According to the CDC/AAP criteria for periodontal disease, 53 (46.5%) participants
presented with no disease, 14 (12.3%) with mild disease, 39 (34.2%) with moderate disease, and
6 (5.3%) with severe disease status. The average of all mean probing depths across all sites was
2.3 (SD = 0.5, Range = 1.4-4.0) and the average of all mean clinical attachment loss was 0.8 (SD
= 1.1, Range = 0.0-6.6). The mean number of teeth with interproximal probing depth of 4mm or
more was 6.3 (SD = 4.5, Range = 0-26), and with 5mm or more was 2.2 (SD = 4.1, Range = 022).
Mean number of teeth with interproximal clinical attachment loss of 3mm or more was
4.5 (SD = 7.2, Range = 0-28), with 4mm or more was 2.3 (SD = 5.0, Range = 0-25), and with
6mm or more was 0.6 (SD = 2.5, Range = 0-19). Given the CDC/AAP categorization, only
clinical attachment loss of 3mm, 4mm, and 6mm are reported. The mean number of missing
teeth (not including third molars/wisdom teeth) was 1.5 (SD = 2.5, Range = 0-12). The mean
percentage of sites that bled on probing was 20.9% (SD = 17.5, Range = 1.0-79.0); the mean
percentage of sites with plaque was 72.5% (SD = 27.9, Range = 1.0-100.0).
The mean Perceived Stress score was 17.2 (SD = 7.1 Range = 0-35) and the average
number of stressful life events over the last year was 3.8 (SD = 3.0, Range = 0-15). Mean serum
zonulin for all participants was 22.8 ng/mL (SD = 5.7, Range = 12.8-38.5) and mean serum IL-6
was 3.2 (SD = 3.5, Range = 0.1-21.6). The total number of teeth with a probing depth of 4mm or
more was significantly correlated with zonulin levels (Pearson r = 0.24, p = 0.014), as was total
of number of teeth with a probing depth of 5mm or more (Pearson r = 0.24, p = 0.014). IL-6
levels also were correlated with number of teeth with an interproximal probing depth of greater
than 4mm (Pearson r = 0.21, p = 0.033) or greater than 5mm (Pearson r = 0.22, p = 0.025),
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respectively. Correlations coefficients for all variables of interest related to hypothesis one and
two are displayed in Table 3.
CDC/AAP Periodontal Status and Zonulin
Related to hypothesis one, zonulin levels—when compared using ANOVA—did not
differ based on the four CDC/AAP status categorizations (n = 107; F(3,103) = 0.673, p = 0.570).
When examining covariates across CDC/AAP status, the only one that differed significantly
across categorizations was participant age (n = 112; F(3, 108) = 6.600, p < 0.001). Participants
with severe periodontal disease (M = 52.5, SD = 13.2) were older on average when compared to
participants with no disease (M = 31.2, SD = 10.7) or mild disease (M = 35.9, SD = 11.6). Means,
standard deviations, counts and percentages for each variable in hypothesis one and two are
displayed in Table 4.
Those with moderate-to-severe periodontal disease were expected to have higher levels
of zonulin than those with otherwise healthy gingiva when accounting for the covariates. Before
including covariates in the model, a simple regression was conducted with the dichotomous
CDC/AAP variable of none-to-mild disease and moderate-to-severe disease predicting zonulin
levels. The model was not statistically significant (n = 107; F(1,105) = 1.41, p = 0.238). When
including the covariates of gender, age, smoking status, diabetes, and BMI, the overall regression
model also was not statistically significant (n = 101; F(6,94) = 1.86, p = 0.095) and results
indicating BMI as a significant predictor of zonulin, are therefore not trustworthy. Similarly,
when CDC/AAP status was treated as a continuous variable, the regression model was nonsignificant (n = 101; F(6,94) = 1.78, p = 0.111). Regression results, including standardized beta
coefficients for both the dichotomous and the continuous models, are displayed in Table 5.
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As a result of these initial findings, CDC/AAP status was replaced in the model with the
number of teeth with interproximal probing depth of 5mm or more as a predicting variable and
all other variables remaining the same; the model was statistically significant (n = 101; F(6,94)
= 2.38, p = 0.035). In this model, (as it was in the non-significant/non-interpretable CDC/AAP
models), BMI was the only significant variable (β = 0.28, p = 0.011), suggesting a positive
association between BMI and zonulin when accounting for the other variables. Number of teeth
with interproximal probing depth of 5mm or more was non-significant at the p < 0.05 level (p =
0.069). When examining the change in r-square, BMI accounted for an additional change in
variance (R2 Change due to BMI = 0.062) for serum zonulin levels. If BMI was removed from the
models, they became non-significant. Table 6 displays the results of the regression model.
Because of the potentially unique association of BMI to zonulin, a stratified analysis was
conducted with two models. One model included only those with high BMI (i.e., at or above the
mean) and the other model included those with BMI below the mean. The high BMI model was
non-significant (n = 11; F(6,4) = 0.65, p = 0.695) and no predictors were significantly associated
with zonulin. Likewise, the low BMI model was non-significant (n = 84; F(6,77) = 1.34, p =
0.251).
Psychological Stress, Zonulin, and IL-6
In terms of hypothesis two, PROCESS handles all missing data via listwise deletion (i.e.,
participant is not included if missing data on any variable in the model). Thus, 93 participants
had complete data for the variables to be included. The total effect model was significant (n =
93; (F(6,86) = 4.20, p = 0.001), though the total effect of psychological stress on IL-6 was not (β
= 0.08, p = 0.481). Similar to the prior hypothesis, the covariate of BMI was a significant
predictor of IL-6 (β = 0.38, p < 0.001). PROCESS was unable to converge and would not
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produce indirect effects in this model. Upon further exploration, there was not enough variability
in the diabetes variable, and when it was removed, the model converged, producing indirect
effects. The overall findings remained the same with BMI as a significant predictor of IL-6. In
both models (with and without the diabetes variable), zonulin was not a significant predictor of
IL-6 levels in the presence of the other variables (β = -0.05, p = 0.655). Without diabetes as a
variable, the indirect effect was calculated and psychological stress via zonulin levels was not
significant. That is, zonulin levels did not mediate the relation between PSS-10 scores and IL-6
levels.
Similarly, when the PSS-10 scores were replaced with total life events (LEL), the total
effect model was significant (n = 93; (F(6,86) = 4.10, p = 0.001) and BMI was the only
significant predictor of IL-6 (β = 0.38, p < 0.001). Also, when diabetes status was removed for
convergence purposes, zonulin levels did not mediate the relation between LEL scores and IL-6
levels. LEL scores were likewise not predictive of IL-6 levels. When BMI was removed, the
model was not significant (n = 98; (F(5,92) = 2.00, p = 0.086).
Additional Exploratory Analyses
As a follow-up to the two a priori hypotheses, a number of post hoc exploratory analyses
were conducted. The purpose of the exploratory analyses was to examine potential relations
between variables that explore alternative theoretical routes of association. For example, it could
be that the categorization of CDC/AAP status does not capture early versus late state periodontal
inflammation or perhaps other negative affective constructs such as depression would be
associated with zonulin levels. Moreover, given the connection of zonulin to dietary factors,
additional analyses were conducted to explore potential connections to nutritional and diet
variables.
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Acute stage versus more advanced periodontal disease parameters. First, given that
the number of teeth with interproximal probing depths of greater than 5mm as a replacement to
CDC/AAP status produced a significant model, but was not a significant predictor of zonulin,
exploratory analyses were conducted with it as a dependent variable. Number of teeth with
interproximal probing depths of 5mm or more is a measure of more acute inflammatory
processes in periodontal conditions. Thus, the same model as with hypothesis one was
conducted, only with zonulin as a predictor and number of teeth with probing depth of 5mm or
more as the dependent variable. All other covariates remained the same (i.e., gender, age, current
smoking status, diabetes status, and BMI). The overall model was significant (n = 101; (F(6,94)
= 4.10, p = 0.001). Zonulin was not a significant predictor of the periodontal probing outcome,
but current smoking status was significantly associated. Those with greater current smoking
levels had a greater number of teeth with deeper pockets (β = 0.28, p = 0.004). BMI, diabetes
status, gender, and age were non-significant. Because periodontal disease is a disease of aging
(Ebersole et al., 2016), another model was tested with age as a dichotomous variable, with 0
associated with the lowest three quartiles and 1 linked with upper most quartile. This age
variable was still not a significant predictor. Results for the regression model with age as a
continuous variable are displayed in Table 7.
A stratified analysis was again conducted to examine one model of non-current smokers
and another with current smokers. The model with those endorsing not currently smoking was
significant (n = 79; (F(5,73) = 3.11, p = 0.013) and interestingly, zonulin was a significant
predictor of periodontal probing depth of 5mm or more (β = 0.25, p = 0.029) such that greater
zonulin levels were associated with number of teeth with deeper probing depths. Age and
diabetes status also were significant predictors (β = 0.23, p = 0.034; β = 0.25, p = 0.042) such
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that increased age and having diabetes were associated with number of teeth with deeper probing
depths.
Next, to assess whether zonulin predicted more advanced stages of periodontal disease,
the number of teeth with interproximal clinical attachment loss of 3mm, 4mm, or 6mm (the
primary parameters used in deciding CDC/AAP categorizations) variables were used in three
separate models, again including the original covariates. The overall model for more teeth with
clinical attachment loss of greater than 3mm was significant (n = 101; (F(6,94) = 5.77, p <
0.001). Zonulin levels, gender, BMI, and diabetes status were not significant. Age (β = 0.41, p <
0.001) and current smoking (β = 0.27, p = 0.004) were significant, suggesting those who are
older and those who are currently smoking some days, or most days had more attachment loss
(i.e., 3mm or greater). Results were similar and the findings the same for a model with clinical
attachment loss of 4mm or more. The model with number of teeth with clinical attachment loss
of 6mm or more was not significant and thus uninterpretable. Results for all three models are
displayed in Table 8.
Additionally, as an exploratory method to identify other potentially relevant variables not
initially included in the model, a stepwise regression analysis was used. Stepwise regression is an
exploratory analysis, it cannot replace theory, and cannot help to explain relations between
variables like experimental or prospective studies might (Keith, 2014). It can be useful, though,
in understanding potential predictors while elevating the variance explained of any given
outcome. Here, a number of variables that have been shown to play a role in periodontal
outcomes were included in a model to predict number of teeth with a probing depth of greater
than 5mm and variables are systematically selected based on which one would contribute the
most to significantly explaining the variance of said outcome. Potential predicting variables
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included zonulin, education level, gender, age, BMI, household income, diabetes status, current
smoking status, perceived stress, and depression scores. The regression resulted in a significant
model (n = 101; (F(4,96) = 6.94, p < 0.001). The four variables that were significant predictors
of number of teeth with an interproximal probing depth of 5mm or more included current
smoking status, serum zonulin level, age, and household income. As current smoking (β = 0.23,
p = 0.014), zonulin (β = 0.23, p = 0.015), and age (β = 0.25, p = 0.009 increased, number teeth
with deeper pockets increased. Those with higher incomes had fewer deep periodontal pockets (β
= -0.22, p = 0.025) and those with lower incomes more. The R-square for this model was 0.22,
suggesting this model accounts for 22 percent of the variance in number of teeth with probing
depths of 5mm or more. Results are displayed in Table 9.
Differences across outcomes related to CDC/AAP status. Building on the alternative
analyses assessing different stages or parameters of periodontal disease, additional analyses were
conducted to explore other variable differences based on the CDC/AAP categorization. Using an
Analysis of Variance (ANOVA), basic differences in zonulin levels, perceived stress, life events,
IL-6, depression scores, fear of pain, and visceral sensitivity were explored based on CDC/AAP
periodontal disease status categories. No significant differences were noted, except in the case of
IL-6 (F(3,103) = 3.84, p = 0.012, η2 = 0.101). Post-hoc analysis (i.e., Tukey Honestly Significant
Difference Tests) determined the difference in CDC/AAP status was such that those in the severe
disease category had significantly higher serum IL-6 levels (Msevere disease = 7.4; SD = 3.5), and
those with no disease (Mno disease = 2.6; SD = 3.8; p = 0.008) or those with mild disease (Mmild
disease =

2.6; SD = 3.1; p = 0.026) lower levels. Those with moderate disease did not differ from

the other CDC/AAP categories (Mmoderate disease = 3.6; SD = 3.0; p = 0.062). Results of the
ANOVA are displayed in Table 10.
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Relation of zonulin to self-reported periodontal symptomology. As another way of
assessing at indicators of periodontal inflammation, PDSR scales were explored. The PDSR
scores were first correlated to clinical periodontal disease parameters including CDC/AAP status,
percent of sites with bleeding on probing, percent of sites with plaque, number of teeth with
interproximal probing depths of 4mm and 5mm or more, number of teeth with interproximal
clinical attachment loss of 3mm, 4mm, and 6mm or more, and number of missing teeth other
than the third molars. PDSR total scores were positively correlated with all clinical parameters
(0.36 < r < 0.53; p < 0.001). The Physiological and Functional symptom subscales were likewise
correlated with all parameters, though only the Functional symptoms subscale was associated
with number of missing teeth (r = 0.37, p < 0.001). Zonulin was not associated with any of the
PDSR scales.
Correlations among other psychosocial or diet variables and zonulin. Given the lack
of association between the stress variables, other psychosocial variables and their associations
with zonulin were explored. Psychosocial, diet, and periodontal disease variables were examined
in a correlation table to explore potential relations to zonulin levels. None of the psychosocial
variables were significantly correlated with serum zonulin. In terms of the diet variables, a
number of vitamin or mineral consumption amounts were negatively correlated with zonulin
including iron, thiamin, niacin, vitamin B-6, folate, and hexadecenoic acid. As the consumption
of each of these minerals and vitamins increased, zonulin levels decreased. Similarly, total grain
intake, along with red meat intake (e.g., beef, veal, pork, lamb, game meat) was negatively
correlated with serum zonulin. After these correlations were discovered, periodontal disease
parameters were added to the correlation table. Almost all of diet variables that were
significantly correlated with zonulin also were correlated with CDC/AAP status or number of

ZONULIN, STRESS, AND PERIODONTAL DISEASE

33

teeth with probing depth of greater than 5mm. The zonulin, dietary/nutritional factors, and
periodontal disease parameter correlations are displayed in Table 11.
Discussion
The primary aims of this study were to explore potential relations between zonulin and
periodontal disease status, as well as the potential mechanistic role of zonulin in the association
between psychological stress and inflammatory markers such as IL-6. Those with moderate-tosevere periodontal disease were expected to have higher levels of zonulin than those with
otherwise healthy gingiva, after accounting for covariates. This would support the hypothesis
that moderate-to-severe periodontal disease may be related to elevated zonulin levels and thereby
possible intestinal permeability. Results from this study did not, however, support this hypothesis
in terms of CDC/AAP moderate-to-severe periodontal disease status being related to serum
levels of zonulin, after controlling for all covariates.
Nevertheless, basic correlations indicated a significant association between increased
number of deeper probing depths and increased serum zonulin, which may suggest it plays a role
in periodontal diseases. The model tested in hypothesis one was significant when the number of
teeth with interproximal probing depths of 5mm or more was used as a periodontal disease
parameter instead of CDC/AAP status, though in the presence of other variables, it did not
predict zonulin levels. Moreover, when the number of probing depths variable was included with
age, gender, diabetes status, and current smoking status, BMI was the only significant predictor
and contributed nearly half of the accounted variance in the model. This finding, however, was
complicated when dropping the two highest BMI participants due to being outliers, resulting in
BMI no longer being a significant predictor. Prior literature that suggests a role of elevated
zonulin levels in obesity and metabolic diseases (Aasbrenn, Lydersen, & Farup, 2020; Moreno-
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Navarrete et al., 2012; Zak-Gołąb et al., 2013), which would support the finding of BMI
associated with zonulin in this study. A novel finding here, however, is the potential relative
weight of BMI in its accounting for the variance of serum zonulin. Elevated BMI, and potentially
obesity, when in the presence of other variables such as age, gender, current smoking status, and
diabetes status was predominant. That is, BMI may be a common predisposing and precipitating
factor together with zonulin in the manifestation of inflammatory states (Wright et al., 2019).
Interestingly, the exploratory results of the stepwise regression replicated important
predictors of periodontal disease predominately demonstrated in epidemiologic literatures. That
is, smoking and household income are well-known risk factors of periodontal disease and was
indicated in the results of this analysis. Noteworthy, however, was that zonulin also was included
as a potential predictor accounting for variance. Moreover, in the stratified analysis of noncurrent smokers, zonulin also was a significant predictor of number of teeth with deeper probing
depths, along with age and diabetes status. This work fits with prior known risk factors of
periodontal disease yet provides some suggestive evidence of zonulin as a potential novel
contributor to the disease. Given the exploratory nature of such an analysis, and in light of
zonulin not being associated in other analyses, more work is needed to explicate the nature of the
relation of zonulin to periodontal inflammation. As mentioned elsewhere, perhaps examining
zonulin in a more proximal location to the inflammation (e.g., gingival crevicular fluid) would
elicit different results.
Results of pilot work leading to this study demonstrated the potential mediating role of
gut-related distress (i.e., gut-specific anxiety) in self-reported periodontal inflammation (Wright
et al., 2021a). Based on these prior data, it was expected that psychological stress and cytokine
levels would be positively associated with zonulin mediating the relation, though this relation
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was not supported by the current study. Even when BMI was taken out of the model, no
significant relations were found. Psychological stress remains a complex construct to study given
it is often used interchangeably with other negative affective terms such as anxiety, fear, or even
pain (Felicione et al., 2021). None of the psychosocial variables were correlated with serum
zonulin levels, suggesting such variables may not have to do much with systemic zonulin or vice
versa, but additional work is needed given this is the first study to examine these relations. The
lack of an association could be related to an overall baseline increase in stress levels resulting
from the COVID-19 pandemic occurring during much of the data collection. Mean PSS-10 levels
were slightly higher than previously published normative data (Cohen & Janicki-Deverts, 2012),
but some of that normative data used in that study are nearly 40 years old. Additional work is
needed to ascertain the effects of COVID-19 on perceived stress and health outcomes.
Furthermore, the complex nature of the relation between acute versus chronic stress and the
immune system cannot be overstated (Segerstrom & Miller, 2004). The PSS-10 and the LEL
used in this study assess the effect of stress or life events over the last month or 12 months,
respectively. It could be that more immediate or short-term stress plays a role in the zonulin
pathway. Additional studies, perhaps experimental in nature, could test the production of zonulin
when a participant undergoes an acute stress task. This study also only assessed for one cytokine,
IL-6. Many other pro-inflammatory and other inflammatory markers could be examined that also
are associated with psychological stress and could be mediated by zonulin.
Discussion of Exploratory Analyses
“Mode of action”. When considering additional findings outside of the initially proposed
hypotheses, something could be said about the potential “mode of action” that zonulin might
play in periodontal inflammation. Results indicated zonulin was more highly associated with
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probing depth, thus substantiating literature outside of periodontology that indicate zonulin
contributes to the innate immune response (Sturgeon & Fasano, 2016). Zonulin similarly could
be operating in the acute inflammatory stages of periodontal disease. That is, exploring the role
of zonulin in periodontal disease could be time dependent, meaning zonulin could be playing a
role in the acute inflammation, and less so in advanced stages of disease that include more
attachment loss or edentulism.
For example, when CDC/AAP status was replaced with number of teeth with
interproximal probing of 5mm or more, the overall model with zonulin as an outcome became
statistically significant. Additionally, the correlation analysis showed a significant association
between serum zonulin levels and the number of teeth with probing depths of 5mm or more.
Probing depths of greater than 5mm alone are indicative of more acute inflammation and “puffy
gums” often seen in gingivitis (Eke et al., 2021), whereas severe attachment loss or even tooth
loss tend to be indicative of more severe periodontal disease (Eke et al., 2021). Given this study
measured systemic zonulin (i.e., via serum), it would be important to examine zonulin at a local
level including in the gingival crevicular fluid to understand whether zonulin is directly
contributing to increased inflammation. Also, given the relative weight of BMI, additional work
could be conducted in large population studies to see whether zonulin contributes much to oral
inflammation at a system level.
When considering the a priori theoretical assumptions of this study, this “mode of
action” information could help in establishing a more complete theoretical model in the future.
While it is still possible that zonulin affects the gut and “settles” in the oral cavity, after this
study it seems more likely that a more targeted, oral cavity-focused mode of action is at play.
With what is known, it is likely that zonulin plays a role in the inflammatory processes of
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periodontal disease, more locally, and are moderated by relevant covariates, especially BMI, and
less so by age or others, though more work is needed to fully explicate these associations. Figure
4 is a directed acyclic graph (DAG) which provides a working theoretical model to help guide
future work elucidating the role of zonulin in periodontal disease etiology and maintenance.
Differences in variables based on CDC/AAP status. The six participants in the severe
periodontal disease status categorization of the CDC/AAP status did not differ from moderate,
mild or no disease groups in key outcome variables such as zonulin, stress, depressive
symptoms, fear of pain, or visceral sensitivity, although it must be noted that few participants are
included in the severe group. Participants with severe periodontal disease based on CDC/AAP
criteria did, however, have significantly higher levels of IL-6 and those with no disease or mild
disease had lower levels. This finding supports prior literature demonstrating the role of IL-6 in
periodontal disease (Irwin & Myrillas, 1998; Nikolopoulos et al., 2008; Tawfig, 2016). IL-6 is a
pro-inflammatory cytokine and aligns with the finding that severe cases have greater levels of
serum level cytokines than those with mild, but not moderate disease. Moderate disease status is
achieved in multiple routes including having two or more interproximal probing depths (not on
the same tooth) of 5 millimeters or more. Severe cases are required to have at least 1 probing site
of 5 or more, in addition to significant attachment loss (National Health and Nutrition
Examination Survey, 2013). Deeper pocket depths often are associated with greater rates of
active inflammation (Eke et al., 2021). Thus, having greater active inflammation is likely to
result in greater system-level (i.e., serum) pro-inflammatory cytokines, such as IL-6.
Zonulin and self-reported periodontal inflammation. This was the first study to
compare the PDSR (Wright et al., 2021b) with clinical parameters of periodontal disease. Results
help to provide evidence of concurrent validity for the PDSR, further establishing it as a possible
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easy-to-use and low-cost alternative to some more time intensive clinical measures. Especially
interesting was how the Physiological symptoms subscale was not associated with tooth loss, but
the Functional symptoms subscale was, substantiating the nature of each subscale. Neither the
total score nor the subscale scores were associated with zonulin despite deep pocket depth being
correlated with zonulin levels.
Diet relations to zonulin and periodontal disease. Overall, there were several
associations between serum zonulin and diet or nutritional factors, including grain intake, red
meat consumption, and a number of vitamins and minerals. Given that intake of gluten (a protein
found in wheat, barley, and rye) and its mechanistic role in zonulin production (Sturgeon &
Fasano, 2016), it was surprising that increased total grain intake was associated with less serum
zonulin. While gluten is more prevalent in breads and grains, so too are minerals and vitamins
such as iron, thiamin, niacin, vitamin B-6, folate, and hexadecenoic acid (Harvard School of
Public Health, 2021), which also were associated with lower levels of zonulin in this study. Bcomplex vitamins typically are more prevalent in grain and red meat-rich diets (Najeeb et al.,
2016), which may partially explain the association among these variables in the current study.
Prior work examining the associations between vitamins and serum zonulin has been sparse,
though one study found similar results as the present study, including higher levels of thiamin,
niacin, and other B-vitamins in those with low levels of serum zonulin (Mokkala et al., 2016).
No known work has examined the association between hexadecenoic acid and zonulin, although
some have explored its roles in combating inflammation and metabolic disorders (de Souza et al.,
2018). Understanding the role of zonulin in this way could be a rich area for further exploration.
Similar associations were found between increased levels of the vitamins or minerals also
associated with zonulin and decreased indication of periodontal disease. These findings are
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consistent with existent literature. Members of the vitamin B complex family such as thiamin,
niacin, vitamin B-6, and folate have demonstrative effects on periodontal health (Najeeb et al.,
2016; Varela-López et al., 2018). Greater level of B-vitamins has been indicative of less
problems with periodontal probing depth and clinical attachment loss (Najeeb et al., 2016), as
well as improvement in periodontal wound healing (Najeeb et al., 2016; Neiva et al., 2005).
Moreover, individuals who smoke—a known predictor of periodontal disease—also tend to have
lower levels of serum folic acid (i.e., synthetic folate; Erdemir & Bergstrom, 2006). Iron rich
diets also play a protective role in periodontal disease due to their anti-oxidative properties
(Chakraborty et al., 2014; Najeeb et al., 2016). Given the commonalities found among the Bvitamins, zonulin production, and periodontal disease characteristics, additional work should be
conducted to elucidate whether there are mechanisms that may contribute to increases in zonulin
and play a potential mediating or moderating role between zonulin and periodontal disease
outcomes.
Additionally, while more work is needed in this area, lesser amounts of zonulin have
been shown to attenuate the effects of those diseases that it has been associated with, including
celiac disease. Indeed, some have tested the effects of a zonulin antagonist (i.e., Larazotide
acetate) in improving symptoms in patients with celiac disease (Leffler et al., 2015). Perhaps
more work could test interventions that target the effects of increased B-vitamins in reducing
zonulin levels and thereby a host of chronic inflammatory ailments.
Limitations
This sample included a disproportionate amount of no disease participants and could have
benefitted from more severe cases. Given the limitations with recruitment during COVID-19,
additional severe cases were difficult to obtain. The lack of statistical differences or larger effects
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could be due, in part, to the small sample of severe cases in comparison to the others. Having
more severe cases could have provided additional power potentially needed to see a greater
effected related to zonulin levels.
Representation in terms of race/ethnicity was good in terms of the number of individuals
who identified as Black or African American, compared to the demographics of West Virginia.
There was less representation in other minority status groups, however, such as those who
identify as Asian, American Indian/Native Alaska, or Latinx. Given work demonstrating
disparities in periodontal disease and oral health more broadly, future work would do well to
examine the role of zonulin and psychological factors among racial and ethnic minority
populations.
The younger mean age of this sample likely contributed to the disproportionate number
of healthy or no disease participants. Periodontal disease is a disease of aging and future work
would do well to include older participants. This was a limitation potentially due to the crosssectional and convenience sampling method of recruiting in a college town where the mean age
in the region is naturally lower. The analyses, however, examining the prediction of zonulin and
covariates in relation to periodontal disease parameters typically associated with more advanced
disease (i.e., number of teeth with clinical attachment loss of 3mm, 4mm, and 6mm ore more)
indicated no association with zonulin, but did with age and smoking status. Age was not a
significant predictor of more acute periodontal disease (i.e., number of teeth with deep pockets).
The comparison of these two findings—age being associated with clinical attachment loss and
late-stage disease, and not with acute inflammation more typical of gingivitis—does indicate that
even though the mean age was potentially skewed to be younger, age still played a role.
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For the hypotheses one and two, 101 and 93 participants had complete data, respectively.
For the mediation analysis, it could be that it was underpowered given the a priori power
analysis. Given the relative weight of BMI in this model, however, it is unlikely that the overall
conclusions would have changed. MPlus was used with a full information likelihood estimator
(FIML) and without diabetes status as a way to provide complete data for 114 participants. The
overall findings did not change.
Similarly, the interpretation of the stepwise regression results should be tempered.
Stepwise regression leans heavily on mathematics and computation to determine the relative
“importance” of any given variable and does not replace good theory (Keith, 2014). That being
said, the results of the analysis in this study were consistent with other risk factors in
periodontology such as age, smoking status, and household income. Such consistency may give
additional credence to the finding of zonulin also being included in this model and the need for
further experimental and microbiological work in understanding the etiological role of zonulin in
periodontal inflammation and disease.
In terms of the self-report periodontal measure (PDSR), a potentially methodological
confound could be that the PDSR was administered after the clinical periodontal examination,
potentially influencing and inflating responses. That is, the participants would be thinking more
attentively to their gum health than the general population. Future work should counter-balance
and account for this potential study effect by having individuals complete the PDSR prior to
undergoing a specialized periodontal examination that could influence their responses.
Directions for Future Research
In terms of future work related to zonulin and its potential association with periodontal
inflammation and/or disease, this study provides preliminary data that makes it logical to conduct
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further microbiological work. That is, microbiologists and cell biologists could benefit this
literature by explicating the role of zonulin in cell-cell adhesion not only in the gastrointestinal
tract, but also the junctional epithelium within the periodontium. Similarly, this study focused on
the systemic associations of zonulin to periodontal disease, which is “downstream” or distal to
where the actual inflammation is occurring. Others should examine a more proximal view by
examining whether zonulin is present in the gingival crevicular fluid, or even saliva. Doing so
could provide evidence that zonulin is operating at a local level as well.
This study did not provide much evidence in terms of the association between stress or
other psychosocial variables and zonulin. This could have been due to the focus on more
temporally distant stress (i.e., PSS-10 measuring stress in last month and the LEL stressors over
the last 12 months). As mentioned previously, additional exploration could be done by
conducting experimental studies with more immediate stressors. This study seemed to indicate a
stronger presence of zonulin in acute inflammation, which may coincide with psychological
variables with more acute inflammatory effects. That being said, this study has implications for
another psychological or behavioral construct, namely diet. This work confirmed some of the
broad associations between B-vitamins and zonulin, and additional work could be done to
understand why these associations and the related mechanisms. Given diet is heavily influenced
by behavior, additional exploration into developing behavioral interventions should be
conducted, particularly those that might influence the B-vitamin pathway and thereby potentially
reduce inflammation that is a result of increased zonulin level.
Summary and Conclusions
This study provided some evidence to suggest a contributing role of zonulin to
periodontal inflammation and disease. As this is the first such study to suggest that zonulin might
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be related to oral inflammation, it potentially has important implications for understanding a
complex disease. This study also suggests little association between psychosocial variables and
zonulin level, except when considering dietary behavior. Other exploratory analyses replicate
findings from prior work including the role of IL-6, smoking status, and age in periodontal
disease, as well as BMI in zonulin. Furthermore, this study demonstrates the importance of
considering the gastrointestinal-periodontal health pathway. Better elucidating how the oral
cavity is affected by other bodily systems will provide new insights into the etiology of oral
diseases, as well as in innovating new treatments. Given the complexity of such a task, team
science across multiple disciplines using transdisciplinary approaches may provide needed
unique perspectives and prompts new ways of asking questions.
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Tables
Table 1
Criteria for classifying periodontitis according to 2012 CDC/AAP recommendations, as well as
number and percentage of sample in each class.
Class of Periodontitis

Criteria

Severe (n = 6 [5.3%])

≥2 interproximal sites (not on the same tooth) with AL ≥
6mm AND ≥1 interproximal site with PD ≥5mm.

Moderate (n = 39 [34.2%])

≥2 interproximal sites (not on the same tooth) with AL ≥
4mm, OR ≥2 interproximal sites with PD ≥ 5mm.

Mild (n = 14 [12.3%])

≥2 interproximal sites with AL ≥3mm, AND ≥2
interproximal sites with PD ≥ 4mm (not on the same
tooth), OR 1 site with PD ≥5mm

No Disease (n = 53 [46.5%])

No evidence of mild, moderate, or severe periodontitis

Note: n = 112 (2 [1.8%] participants did not undergo periodontal examination due to complete
edentulism.)
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Table 2
Descriptive characteristics of sample (N = 114).
Mean / N
36.1

SD / %
14.0

Age (years)
Gender
Female
58
50.9%
Male
50
43.9%
Other
3
2.6%
Missing
3
2.6%
Race/Ethnicity
White
86
75.3%
Black/African American
24
21.1%
Asian
1
0.9%
American Indian/Native American
1
0.9%
Other
1
0.9%
Missing
1
0.9%
Education (Years)*
15.2
2.9
Income
Less than $10,000
17
14.9%
$10,000-$14,999
20
17.5%
$15,000-$24,999
16
14.0%
$25,000-$34,999
20
17.5%
$35,000-$49,999
8
7.0%
$50,000-$74,999
18
15.8%
$75,000-$99,999
3
2.6%
$100,000-$149,999
4
3.5%
$150,000-$199,999
6
5.3%
Missing
2
1.8%
Body Mass Index (BMI)*
28.2
8.2
Diabetes Status
Yes
3.5%
4F
No
108
94.7%
Missing
2
1.8%
Current Smoker
Not at all
88
77.2%
Some days
9
7.9%
Every day
16
14.0%
Missing
1
0.9%
F
Notes: *=7 missing Education; 7 missing Body Mass Index; =2 type II and 2 type I diabetes.
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Table 3
Correlation table of all primary variables using Pearson correlation coefficients.
1
1 Zonulin

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

-

2 IL-6

0.03

-

3 CDC/AAP Status

0.10

0.25*

-

4 # teeth with PD 4+

0.24*

0.21*

0.68+

-

5 # of teeth with PD 5+

0.24*

0.22*

0.68+

0.86+

-

6 # of teeth with CAL 3+

0.10

0.31+

0.71+

0.69+

0.70+

-

7 # of teeth with CAL 4+

0.08

0.32*

0.62+

0.69+

0.74+

0.90+

-

8 # of teeth with CAL 6+

0.06

0.17

0.42+

0.53+

0.64+

0.55+

0.74+

-

9 % sites with BOP

0.02

0.12

0.37+

0.55+

0.48+

0.30+

0.37+

0.38+

-

10 % sites with plaque

0.09

0.21

0.29+

0.41+

0.33+

0.28+

0.30+

0.18

0.43+

-

11 PSS

-0.02

0.07

-0.04

-0.09

-0.09

-0.04

-0.04

0.04

-0.08

0.08

-

12 LEL

-0.17

-0.10

-0.13

-0.04

-0.04

-0.11

-0.10

-0.10

-0.04

0.05

0.43+

-

13 Age

0.10

0.19

0.37+

0.12

0.23*

0.43+

0.38+

0.21*

0.04

-.07

-.23*

-0.18

-

14 Gender

0.10

0.06

0.14

0.22*

0.22*

0.10

0.12

0.01

0.14

0.19

-.29+

-0.02

0.18

-

15 Current Smoker

0.08

0.17

0.27+

0.28+

0.36+

0.31+

0.26+

0.23*

0.07

0.28+

0.23*

0.20*

0.05

0.10

-

16 BMI

0.25*

0.41+

0.13

0.18

0.15

0.14

0.19*

0.07

0.17

0.09

-0.04

-0.06

0.12

0.05

0.09

-

17 Diabetes

-0.03

0.22*

0.04

-0.04

0.03

0.11

0.11

0.10

0.04

0.17

0.07

-0.02

0.11

0.02

0.13

0.26+

Notes: * = p < .05. + = p < .01. Italics indicates Spearman’s rho was used instead of Pearson r. Bold indicates statistically significant.

-
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Table 4
Mean scores for variables included in hypothesis one and two by CDC/AAP status.
CDC/AAP Status - M (SD) / n (%)
No disease
(n = 53)
22.5 (4.9)

Mild
(n = 14)
21.6 (7.5)

Moderate
(n = 39)
23.4 (6.1)

Severe
(n = 6)
24.9 (6.3)

IL-6 (n = 107)

2.6 (3.8)

2.6 (3.1)

3.6 (3.0)

7.4 (3.5)

0.012

PSS Total (n =111)

17.5 (7.4)

17.4 (7.5)

16.8 (6.6)

16.7 (8.8)

0.974

# of life events (n = 112)

4.1 (3.0)

4.2 (2.9)

3.5 (3.1)

2.3 (2.7)

0.475

31.2 (10.7)

35.9 (11.6)

39.6 (15.9)

52.5 (13.2)

< 0.001

Zonulin (n = 107)

Age (n = 112)
Gender (n = 106)

0.570

0.126

Women (n/% of total)

33 (63.5%)

4 (30.8%)

19 (52.3%)

2 (33.3%)

Men (n/% of total)

19 (36.5%)

9 (69.2%)

16 (45.7%)

4 (66.7%)

Smoking status (n = 111)

0.2 (0.6)

0.3 (0.7)

0.5 (0.8)

0.8 (1.0)

Diabetes (n = 110)

0.071
0.317

Yes (n/% of total)

2 (3.8%)

0 (0%)

1 (2.7%)

1 (16.7%)

No (n/% of total)

51 (96.2%)

14 (100%)

36 (97.3%)

5 (8.3%)

27.4 (7.8)

29.0 (12.6)

28.5 (6.3)

33.7 (10.1)

BMI (n = 106)

p-value

0.350

Notes: p-values determined by ANOVA in case of continuous variables and chi-square for
categorical variables. Bold indicates statistical significance. PSS = Perceived Stress Score; BMI
= Body mass index.

ZONULIN, STRESS, AND PERIODONTAL DISEASE

61

Table 5
Regression results of CDC/AAP status dichotomized and as continuous predicting zonulin levels
and accounting for covariates.
b

S.E.

t

p - value

15.802

2.453

6.442

< .001

CDC/AAP dichotomous

.927

1.226

.080

.756

.452

Gender (Male)

1.159

1.120

.102

1.026

.308

Age

.013

.043

.033

.314

.754

Current smoking status

-.002

.811

.000

-.003

.998

BMI

.206

.074

.297

2.778

.007

-5.205

3.296

-.170

-1.579

.118

b

S.E.

β

t

p - value

15.783

2.466

6.400

< .001

CDC/AAP continuous

.233

.611

.042

.381

.70

Gender (Male)

1.119

1.135

.098

.987

.326

Age

.018

.043

.043

.405

.687

Current smoking status

.059

.816

.007

.073

.942

BMI

.206

.074

.297

2.768

.007

-5.223

3.304

-.170

-1.581

.117

Intercept

Diabetes (Yes)
Intercept

Diabetes (Yes)

β

Notes: b = unstandardized coefficient and β = standardized coefficient. S.E. = standard error.
CDC/AAP dichotomous was coded as 0 = no disease or mild disease and 1 = moderate or severe
disease status. CDC/AAP continuous was coded as 0 = no disease, 1 = mild disease, 2 =
moderate disease, and 3 = severe disease status.
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Table 6
Regression results with number of teeth with interproximal probing depth of 5 or more
millimeters predicting zonulin levels while accounting for covariates.
b

S.E.

t

p - value

16.429

2.446

6.717

.000

.268

.146

.195

1.839

.069

Gender (Male)

.792

1.130

.069

.701

.485

Age

.009

.041

.022

.218

.828

Current smoking status

-.299

.814

-.038

-.368

.714

BMI

.191

.074

.276

2.600

.011

-4.866

3.254

-.159

-1.495

.138

Intercept
# of teeth w/ interproximal
probing depth of 5mm+

Diabetes (Yes)

β

Notes: b = unstandardized coefficient and β = standardized coefficient. S.E. = standard error.
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Table 7
Regression results with zonulin predicting the number of teeth with the of number interproximal
probing depth of 5 or more millimeters as outcome and while accounting for original covariates.
b

S.E.

Intercept

-4.781

2.006

Zonulin

.129

.070

Gender (Male)

1.175

Age

β

t

p - value

-2.383

.019

.178

1.839

.069

.777

.142

1.512

.134

.051

.028

.173

1.843

.069

Current smoking status

1.591

.541

.276

2.939

.004

BMI

.038

.053

.076

.725

.470

Diabetes (Yes)

-.793

2.284

-.036

-.347

.729

Notes: b = unstandardized coefficient and β = standardized coefficient. S.E. = standard error.
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Regression results with zonulin predicting the number of teeth with an interproximal clinical
attachment loss of 3 millimeters, 4 millimeters, or 6 millimeters as outcome and while
accounting for original covariates, respectively.
# of teeth w/CAL of 3mm+
b
S.E.
β
t
p - value
Intercept
-6.906
3.353
-2.060
.042
Zonulin
.046
.118
.036
.387
.700
Gender (Male)
.221
1.299
.015
.170
.865
Age
.210
.046
.406
4.518
< .001
Current smoking status
2.666
.905
.266
2.946
.004
BMI
.061
.088
.069
.692
.491
Diabetes (Yes)
.238
3.818
.006
.062
.950
# of teeth w/CAL of 4mm+
b
S.E.
β
t
p - value
Intercept
-5.168
2.392
-2.160
.033
Zonulin
.017
.084
.020
.204
.839
Gender (Male)
.250
.927
.025
.270
.788
Age
.126
.033
.353
3.811
< .001
Current smoking status
1.409
.646
.203
2.183
.032
BMI
.063
.063
.104
1.003
.318
Diabetes (Yes)
2.111
2.724
.079
.775
.440
# of teeth w/CAL of 6mm+
b
S.E.
β
t
p - value
Intercept
-1.348
1.266
-1.064
.290
Zonulin
.015
.044
.035
.343
.733
Gender (Male)
.177
.491
.036
.361
.719
Age
.032
.018
.179
1.811
.073
Current smoking status
.817
.342
.238
2.389
.019
BMI
-0.0001
.033
.000
-.002
.999
Diabetes (Yes)
.885
1.442
.067
.613
.541
Notes: b = unstandardized coefficient and β = standardized coefficient. S.E. = standard error.
CAL = clinical attachment loss. Model with number of teeth with CAL of 6mm+ was nonsignificant.
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Table 9
Results of an exploratory stepwise regression that included series of potential variables.
Model 1

b

S.E.

Intercept

1.561

.443

smokenow

1.728

.552

t

p - value

3.520

.001

.300

3.131

.002

b

S.E.

β

t

p - value

Intercept

-2.298

1.604

-1.433

.155

smokenow

1.709

.538

.297

3.177

.002

Zonulin

.169

.068

.233

2.498

.014

b

S.E.

β

t

p - value

Intercept

-4.046

1.778

-2.276

.025

Current smoking

1.656

.529

.288

3.130

.002

Zonulin

.155

.067

.213

2.310

.023

Age

.058

.027

.196

2.124

.036

b

S.E.

β

t

p - value

Intercept

-3.535

1.756

-2.014

.047

Current smoking

1.348

.536

.234

2.516

.014

Zonulin

.163

.066

.225

2.486

.015

Age

.074

.028

.250

2.670

.009

Household income -.398

.175

-.218

-2.269

.025

Model 2

Model 3

Model 4

β

Notes: b = unstandardized coefficient and β = standardized coefficient. S.E. = standard error.

ZONULIN, STRESS, AND PERIODONTAL DISEASE

66

Table 10
Results of exploratory ANOVA assessing the differences in listed variables by CDC/AAP
periodontal disease status.
Sum of
Squares
PSS Total

Between Groups

FPQ9 Total

VSI Total

Square

3

3.85

Within Groups

5555.47

107

51.92

Total

5567.03

110

23.21

3

7.74

Within Groups

994.21

108

9.21

Total

1017.42

111

66.86

3

22.29

Within Groups

3409.97

103

33.11

Total

3476.83

106

Between Groups

134.80

3

44.93

Within Groups

1203.84

103

11.69

Total

1338.63

106

Between Groups

282.08

3

Zonulin (ng/mL) Between Groups

CESD Total

Mean

11.56

LEL Total Events Between Groups

Serum IL-6

df

Within Groups

13999.88 101

Total

14281.96 104

Between Groups

94.03

3

5.90

Within Groups

6256.19

103

60.74

Total

6273.87

106

15.90

3

Within Groups

22336.06 101

Total

22351.96 104

.074 .974

.840 .475

.673 .570

3.844 .012

.678 .567

138.61

17.68

Between Groups

F P-value

5.30

.097 .961

.024 .995

221.15

PSS = Perceived Stress Scale; LEL = Life Events List; IL-6 = interlukin-6; CESD = Center for
Epidemiologic Studies Depression; FPQ9 = Fear of Pain Questionnaire-9; VSI = Visceral
Sensitivity Index
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Table 11
Pearson correlation table of zonulin, IL-6, and dietary/nutritional factors.
2

1
1 Zonulin ng/mL

3

5

6

7

8

9

10

11

12

13

14

15

16

17

--

2 Serum IL-6

.03 --

3 CDC/AAP

.10

4 PD 5mm+

.24*

.22*

-.27**

5 Iron

4

.25** -.68** --

-.06

-.17

**

-.09

*

-.24*

7 Niacin (mg)

-.21*

-.07

-.01

-.07

.62**

.72** --

8 Vitamin B6 (mg)

-.25*

-.10

.01

-.02

.48**

.59**

.83** --

9 Folate

-.23*

-.03

-.25*

-.24*

.75**

.76**

.58**

.38** --

10 Folate DFE

-.23*

.01

-.21*

-.23*

.74**

.73**

.57**

.36**

.98** --

11 Fatty acids

-.19

-.08

-.25**

-.21*

.53**

.56**

.46**

.35**

.44**

.39** --

-.21*

-.07

-.25**

-.21*

.57**

.61**

.52**

.39**

.49**

.44**

.98** --

-.30**

-.02

-.08

-.14

.53**

.47**

.56**

.40**

.40**

.38**

.78**

.78** --

14 Total Grains

-.20*

-.06

-.26**

-.23*

.70**

.74**

.49**

.22*

.70**

.69**

.51**

.57**

15 Red Meats

-.20*

-.05

.15

.09

.39**

.25**

.39**

.46**

.07

.05

.15

.14

.30**

.10

**

**

**

.03

*

*

**

**

-.18

-.31**

**

*

**

.07

.90** --

-.13

.01

.55**

6 Thiamin (mg)

12 H. acid
13 H. acid, undiff.

16 CAL 3mm+

-.28

17 CAL 4mm+

.08

18 CAL 6mm+

.06

.31

**

.32

.17

-.22

.71

-.18 --

-.18

-.18

.62

**

.74

-.16

*

-.14

-.04

.42**

.64**

-.09

-.18

-.14

-.09

**

.70

.78** --

-.22

-.07

-.23

-.20

*

-.17

-.17

-.16

-.20

-.29

**

-.26

-.14

-.29

-.27

-.13

.33** --

-.20

-.15

-.01 --.28

.13 -.74** --

Notes: *=Correlation is significant at the 0.05 level (2-tailed). **=Correlation is significant at the 0.01 level (2-tailed). 4=# of teeth with interproximal sites of
5mm or more. H.acid=Hexadecenoic acid. H. acid, undiff=Hexadecenoic acid, undifferentiated. 16, 17, 18=# of teeth with interproximal sites of clinical
attachment loss of 3mm, 4mm, or 6mm or more, respectively.
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Figures

Trigger*

Dysbiosis and
zonulin release

Increase in intestinal
permeability

Pro-inflammatory
cytokines
(IL-6)

Influx of dietary
microbial antigens

Chronic inflammation

Figure 1. Model of zonulin pathway adapted from Sturgeon and Fasano (2016). *In Celiac
disease, the specific trigger is gliadin (a peptide found in gluten). In other diseases, the trigger is
not necessarily known.
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Figure 2. Model depicting hypothesis one. Those with moderate to severe periodontal disease are
anticipated to have higher zonulin levels compared to those with no disease or mild disease, all
while accounting for covariates.
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Figure 3. Model depicting hypothesis two. Zonulin is anticipated to meditate the relation
between psychological stress and cytokine levels such that increased stress will lead to increased
zonulin and thereby, increased cytokines while accounting for covariates.

ZONULIN, STRESS, AND PERIODONTAL DISEASE

71

Figure 4. Directed acyclic graph (DAG) depicting theoretical model of the role of zonulin in the
etiology and maintenance of periodontal disease that could be used in future work.

